New shot aims to break Malaria's cycle of infection
NCT ID NCT06413108
Summary
This study tested a new lab-made antibody, called TB31F, in Mali to see if it could safely help stop the spread of malaria. Researchers gave the antibody to 167 adults and children who are regularly exposed to malaria to check for side effects and to measure how long it lasts in the body. A key goal was to see if the antibody could reduce the chance that a mosquito could pick up the malaria parasite from an infected person and pass it to someone else.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALARIA FALCIPARUM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Faculty of Pharmacy and Faculty of Medicine and Dentistry, University of Sciences Techniques and Technologies of Bamako
Bamako, Point G, BP1805, Mali
Conditions
Explore the condition pages connected to this study.